Femoral bone mineral density as a tool of personalized medicine for rheumatoid arthritis: Interleukin-6 inhibitors for patients with low density whereas tumor necrosis factor inhibitor for patients with preserved density?

SAGE Open Med · 2024 · PMC11418348 · PMID 39315386

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginal significancep = 0.06so close (0.05 < p ≤ 0.1)

The median Health Assessment Questionnaire-Disability Index (HAQ-DI) after 3 months of TCZ treatment decreased from 1.13 only to 0.63 in group H IL-6i , whereas in group L, it decreased from 1.25 to 0.19, with numerically greater difference in group L with marginal significance ( p = 0.06).

also in 3,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.